| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.19 | 0.0001 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.17 | 0.0006 |
| mRNA | MP470 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0007 |
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.001 |
| mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.16 | 0.002 |
| mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.003 |
| mRNA | ATRA | CTRPv2 | pan-cancer | AAC | 0.083 | 0.01 |
| mRNA | pandacostat | CTRPv2 | pan-cancer | AAC | 0.089 | 0.01 |